Skip to main content

Advertisement

SpringerLink
Log in

A conservative management is preferable in milder forms of pituitary tumor apoplexy

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Aim: Our objective was to report a single-center experience of the management of pituitary tumor apoplexy. Patients and methods: We retrospectively analyzed a series of 44 patients hospitalized for pituitary apoplexy between January 1996 and March 2008 at the Timone Hospital, Marseille, France. Results: Most frequent presenting symptoms were headaches (93%), visual impairment (85%) and vomiting (59%). Hypopituitarism was present at diagnosis in 88% of patients, with a high incidence of corticotroph deficiency (70%). A risk factor was found in 52% of patients, mostly hypertension. Apoplexy occurred in a previously undiagnosed pituitary adenoma in 32/44 cases (73%). The apoplectic event concerned 12 secreting, 27 non-functioning, 4 uncharacterized adenomas and one Rathke’s pouch cyst. Nineteen patients underwent surgery within the first month, and one patient had conventional radiotherapy. Twenty-four patients, who had no ophthalmic or neurological signs, were conservatively treated in first intention; among them, 6 received high dose corticosteroids. After a median follow-up of 21 months, there was no significant difference in terms of endocrine or visual recovery between the operated and the conservatively treated groups, nor between patients treated with corticosteroids or not. Panhypopituitarism was observed in 52% of patients, but partial or complete visual recovery was present in the majority of patients (91%), whatever the therapeutic approach. Conclusion: The outcome of patients treated with or without surgery for pituitary apoplexy without severe neuro-ophthalmic deficits seems to be identical, pleading for a conservative management of pituitary apoplexy in the absence of visual emergency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cardoso ER, Peterson EW. Pituitary apoplexy: a review. Neurosurgery 1984, 14: 363–73.

    Article  PubMed  Google Scholar 

  2. Nawar RN, AbdelMannan D, Selman WR, Arafah BM. Pituitary tumor apoplexy: a review. J Intensive Care Med 2008, 23: 75–90.

    Article  PubMed  Google Scholar 

  3. Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ. Acute management of pituitary apoplexy — surgery or conservative management? Clin Endocrinol (Oxf) 2004, 61: 747–52.

    Article  Google Scholar 

  4. Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 1995, 80: 2190–7.

    PubMed  Google Scholar 

  5. Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA, Mansell P. Pituitary apoplexy: retrospective review of 30 patients — is surgical intervention always necessary? Br J Neurosurg 2006, 20: 379–85.

    Article  PubMed  Google Scholar 

  6. Bills DC, Meyer FB, Laws ER Jr, et al. A retrospective analysis of pituitary apoplexy. Neurosurgery 1993, 33: 602–8; discussion 608–9.

    Article  PubMed  Google Scholar 

  7. Dubuisson AS, Beckers A, Stevenaert A. Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 2007, 109: 63–70.

    Article  PubMed  Google Scholar 

  8. Mohr G, Hardy J. Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol 1982, 18: 181–9.

    Article  PubMed  Google Scholar 

  9. Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 1981, 55: 187–93.

    Article  PubMed  Google Scholar 

  10. Nielsen EH, Lindholm J, Bjerre P, et al. Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma. Clin Endocrinol (Oxf) 2006, 64: 319–22.

    Article  Google Scholar 

  11. Sheehan HL, Davis JC. Pituitarynecrosis. Br Med Bull 1968, 24: 59–70.

    Google Scholar 

  12. Semple PL, De Villiers JC, Bowen RM, Lopes MB, Laws ER Jr. Pituitary apoplexy: do histological features influence the clinical presentation and outcome? J Neurosurg 2006, 104: 931–7.

    Article  PubMed  Google Scholar 

  13. Rolih CA, Ober KP. Pituitaryapoplexy. Endocrinol Metab Clin North Am 1993, 22: 291–302.

    PubMed  Google Scholar 

  14. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 1999, 51: 181–8.

    Article  Google Scholar 

  15. Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitaryapoplexy. J Neurol Neurosurg Psychiatry 2001, 71: 542–5.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Tan TM, Caputo C, Mehta A, Hatfield EC, Martin NM, Meeran K. Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report. J Med Case Reports 2007, 1: 74.

    Article  PubMed Central  Google Scholar 

  17. Maiza JC, Bennet A, Thorn-Kany M, Lagarrigue J, Caron P. Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature. Pituitary 2004, 7: 189–92.

    Article  PubMed  Google Scholar 

  18. de Heide LJ, van Tol KM, Doorenbos B. Pituitary apoplexy presenting during pregnancy. Neth J Med 2004, 62: 393–6.

    PubMed  Google Scholar 

  19. Arafah BM, Taylor HC, Salazar R, Saadi H, Selman WR. Apoplexy of a pituitary adenoma after dynamic testing with gonadotropin-releasing hormone. Am J Med 1989, 87: 103–5.

    Article  PubMed  Google Scholar 

  20. Yoshino A, Katayama Y, Watanabe T, et al. Apoplexy accompanying pituitary adenoma as a complication of preoperative anterior pituitary function tests. Acta Neurochir (Wien) 2007, 149: 557–65; discussion 565.

    Article  Google Scholar 

  21. Rotman-Pikielny P, Patronas N, Papanicolaou DA. Pituitary apoplexy induced by corticotrophin-releasing hormone in a patient with Cushing’s disease. Clin Endocrinol (Oxf) 2003, 58: 545–9.

    Article  Google Scholar 

  22. Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 2004, 16: E6.

    Article  PubMed  Google Scholar 

  23. Chanson P, Lepeintre JF, Ducreux D. Management of pituitary apoplexy. Expert Opin Pharmacother 2004, 5: 1287–98.

    Article  PubMed  Google Scholar 

  24. Semple PL, Webb MK, de Villiers JC, Laws ER Jr. Pituitary apoplexy. Neurosurgery 2005, 56: 65–72; discussion 72–3.

    PubMed  Google Scholar 

  25. Nishioka H, Haraoka J, Miki T. Spontaneous remission of functioning pituitary adenomas without hypopituitarism following infarctive apoplexy: two case reports. Endocr J 2005, 52: 117–23.

    Article  PubMed  Google Scholar 

  26. Elsasser Imboden PN, De Tribolet N, Lobrinus A, et al. Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months. Medicine (Baltimore) 2005, 84: 188–96.

    Article  Google Scholar 

  27. Liu JK, Couldwell WT. Pituitary apoplexy in the magnetic resonance imaging era: clinical significance of sphenoid sinus mucosal thickening. J Neurosurg 2006, 104: 892–8.

    Article  PubMed  Google Scholar 

  28. Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I. Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien) 2005, 147: 151–7; discussion 157.

    Article  Google Scholar 

  29. Khaldi M, Ben Hamouda K, Jemel H, Kallel J, Zemmel I. [Pituitary apoplexy. Report of 25 patients]. Neurochirurgie 2006, 52: 330–8.

    Article  PubMed  Google Scholar 

  30. Sibal L, Ball SG, Connolly V, et al. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 2004, 7: 157–63.

    Article  PubMed  Google Scholar 

  31. Rogg JM, Tung GA, Anderson G, Cortez S. Pituitary apoplexy: early detection with diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2002, 23: 1240–5.

    PubMed  Google Scholar 

  32. da Motta LA, de Mello PA, de Lacerda CM, Neto AP, da Motta LD, Filho MF. Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis. J Neurosurg Sci 1999, 43: 25–36.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Timone Hospital, Assistance Publique-Hôpitaux de Marseille and Université de la Méditerranée, Marseille, France

    C. Leyer, F. Castinetti, I. Morange, M. Gueydan, C. Oliver, B. Conte-Devolx & Th. Brue MD, PhD

  2. Department of Neurosurgery, National Reference Center for Rare Pituitary Diseases DEFHY, Timone Hospital, Assistance Publique-Hôpitaux de Marseille and Université de la Méditerranée, Marseille, France

    H. Dufour

Authors
  1. C. Leyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Castinetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Morange
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Gueydan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Oliver
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Conte-Devolx
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Dufour
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Th. Brue MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Th. Brue MD, PhD.

Additional information

Both authors contributed equally to the work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leyer, C., Castinetti, F., Morange, I. et al. A conservative management is preferable in milder forms of pituitary tumor apoplexy. J Endocrinol Invest 34, 502–509 (2011). https://doi.org/10.3275/7241

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/7241

Key-words

Search

Navigation